Healthy Returns: Biotech IPOs ramped up to start 2024, but the market hasn't fully recovered just yet
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! After a two-year dry spell, initial public offerings by biotech companies showed signs of life during the first three months of 2024. But it’s too early to say that the biotech IPO market has fully […]